Results 131 to 140 of about 3,657 (192)

Real-world safety profile of novel anti-multidrug-resistant tuberculosis drugs: a disproportionality analysis based on the FAERS database. [PDF]

BMJ Open
Zhao L, Zeng L, Qian Y, Zhao W, Xie R.
europepmc   +1 more source

Therapy-induced cardiotoxicity in drug-resistant tuberculosis patients: A systematic review and meta-analysis. [PDF]

Glob Cardiol Sci Pract
Liastuti LD, Kohar K, Lestari HM, Pritazahra A.   +3 more
europepmc   +1 more source

Reply to Liao <i>et al.</i>: Optimizing Levofloxacin Dosing for Multidrug-resistant Tuberculosis in Low-Fat-Free Mass Asian Populations. [PDF]

Am J Respir Crit Care Med
Phillips PPJ, Peloquin CA, Sterling TR, Mitnick CD, Horsburgh CR.   +4 more
europepmc   +1 more source

Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial. [PDF]

Contemp Clin Trials
Kendall MA, Hughes MD, Kim S, Aaron LA, Naini L, Suryavanshi N, Shah NS, Rouzier V, Hafkin J, Sise T, Beck J, Heckman BE, Haberer JE, Harrington M, Scarsi KK, Hesseling AC, Swindells S, Churchyard GJ, Gupta A.   +18 more
europepmc   +1 more source

The pharmacokinetics (PK) / pharmacodynamics (PD) of pretomanid, delamanid and bedaquiline in the BALB/c mouse model of central nervous system tuberculosis. [PDF]

BMC Infect Dis
Zhu H, Ye Y, Fu L, Zhang W, Wang B, Chen X, Lu Y.   +6 more
europepmc   +1 more source

Recent advances in tuberculosis treatment: Towards shorter, safer, and more effective therapies. [PDF]

J Clin Tuberc Other Mycobact Dis
Timboe K, Jackson JB, Becker GL.
europepmc   +1 more source

Effectiveness and Safety of Bedaquiline-Containing Modified Shorter Regimens for Multidrug- or Rifampicin-Resistant Tuberculosis: A Single-Arm Meta-Analysis. [PDF]

Pathogens
Zhou Y, Niu H.
europepmc   +1 more source

Anti-tuberculous drug-induced DRESS syndrome in pregnancy with hepatitis E and autoimmune overlap: A case report. [PDF]

Medicine (Baltimore)
Alam MT, Kashif SM, Luqman M, Raja S, Bashir A, Ali A, Lal H, Chaulagain A.   +7 more
europepmc   +1 more source

A New Era in Tuberculosis Prevention and Treatment: Breakthroughs in Drug Development and Future Prospects. [PDF]

Infect Dis Ther
Zhao CY, Song C, Lu YB, Huang AC, Zeng CM, Liu RH, Li WW, Xie ZH, Zhu QD.   +8 more
europepmc   +1 more source

Synergism in drug combination of new tuberculosis antibiotics for drug-resistant <i>Mycobacterium tuberculosis in vitro</i>. [PDF]

Microbiol Spectr
Huang R, He Y, Yang J, Liu Y, Sun Q, Ying R, Sha W.   +6 more
europepmc   +1 more source